Reprogrammed immune cells improve mobility for stiff person syndrome patients
An experimental cell therapy delivered long lasting symptom relief to patients suffering from a severe autoimmune movement disorder. Participants reported substantial improvements in walking ability and balance over a two year monitoring window.
